Abstract
Scleroderma/systemic sclerosis (Scl/SSc) is a heterogeneous disease which can involve internal organ and cause death. When myopathy occurred in Scl/SSc, it is associated with poor prognosis and with more frequent cardiopulmonary involvement. Because the myositis disease concept is changing and the diagnosis of polymyositis may not exist, it may affect Scl/SSc with ``myositis overlap''. In the current study, we try to elucidate the features of myopathy in Scl/SSc patients mainly from a histopathological point of view.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
